Delivery Order SPE2DB24D3015-SPE2DB25FGAZL
- Not listed
- The Defense Logistics Agency awarded a $9,280.01 delivery order to AmerisourceBergen Drug Corp on June 17, 2025, for the supply of Prezcobix 800 mg-150 mg tablets in quantities of 30 units. This is a firm fixed-price, competitively awarded contract with no set-aside designation, scheduled for completion by June 18, 2025. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- This is a $14,491.45 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of PREZCOBIX 800 MG-150 MG tablets, a medication used in the treatment of HIV infection. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which...
- The Defense Logistics Agency awarded a delivery order valued at $5,282.14 to AmerisourceBergen Drug Corp for the supply of Prezcobix 800 mg-150 mg tablets (30-count units) on August 27, 2025, with an ultimate completion date of August 28, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $6,086.41 to AmerisourceBergen Drug Corp for the supply of Prezcobix 800 mg-150 mg tablets (30-count) on November 5, 2025, with completion expected by November 6, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement needs,...
- The Defense Logistics Agency awarded a $57,765.58 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Prezco bix 800 mg-150 mg tablets (30-count) on September 26, 2025, with completion scheduled for September 29, 2025. This non-set-aside competitive award is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $67,667.17 to AmerisourceBergen Drug Corp for the supply of Prezcobix 800 mg-150 mg tablets (30-count units) on August 26, 2025, with completion scheduled for August 27, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen...
- This federal contract award, valued at $90,772.63, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PREZCOBIX 800 MG-150 MG tablets, a medication used to treat HIV infection. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which is valued at $999,999,999 and runs through...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on September 8, 2025, to supply Prezista 800 mg tablets (30-count units) to the Defense Logistics Agency's Medical Supply Chain. The contract is valued at approximately $12.7K under firm fixed pricing with a completion date of September 9, 2025. This award represents a non-competitive delivery order issued under AmerisourceBergen's existing Indefinite Delivery...
- This is a $57,504.07 firm fixed-price delivery order awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA) for the procurement of PREZCOBIX 800 MG-150 MG TABLET 30S. The contract has an ultimate completion date of March 6, 2025 and was awarded on March 5, 2025. The contract is not designated with a set-aside. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that specializes in supplying medical products to federal government agencies, including the...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,048.49, is for the delivery of PREZCOBIX 800 MG-150 MG TABLET 30S, a pharmaceutical product. The contract is a delivery order under an Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This...
- SPE2DB24D3015Indefinite Delivery Contract
- SPE2DB24D3015-SPE2DB25FGAZLDelivery Order
The Defense Logistics Agency awarded a $4,571.79 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 30-count tablets of Prezcobix (800 mg-150 mg), an antiretroviral medication used to treat HIV. The award, issued on September 15, 2025, with an ultimate completion date of September 16, 2025, represents a competitive procurement with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is the place of performance for this order and serves as a critical pharmaceutical distributor for federal medical procurement needs across military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999.00 through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications and medical commodities to support military healthcare programs worldwide. AmerisourceBergen's demonstrated capability to fulfill federal medical requirements through open competition, coupled with its extensive pharmaceutical portfolio spanning multiple therapeutic domains, positions it as a prime vendor for the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.6k | 9/15/25 |